The spread of extended-spectrum β-lactamases (ESBLs) in nosocomial and community-
acquired enterobacteria is an important challenge for clinicians as the therapeutic options …

Background Infections due to extended-spectrum beta-lactamase (ESBL)-producing
Enterobacteriaceae pose a major public health threat due to poor outcomes and high …

The ongoing pandemic of extended-spectrum β-lactamase-producing Enterobacteriaceae
(ESBL-E) is responsible for a global rise in carbapenem consumption that may hasten the …

During the last decade, community-acquired extended-spectrum beta-lactamase (ESBL)-
producing bacteria, and in particular Escherichia coli producing ESBLs of the CTX-M-type …

Since 2000, Escherichia coli producing CTX-M enzymes (especially CTX-M-15) have
emerged worldwide as important causes of community-onset urinary tract infections (UTIs) …

Extended spectrum β-lactamase (ESBL)-producing organisms pose unique challenges to
clinical microbiologists, clinicians, infection control professionals and antibacterial-discovery …

Results of a 2003 survey carried out in Italy to evaluate the prevalence of extended-
spectrum β-lactamase (ESBL)-producing enterobacteria are presented. Eleven Italian …

Background The optimal treatment regimen for infections caused by wild-type AmpC β-
lactamase-producing Enterobacterales remains controversial. This study compared the …

A recent, frequently quoted study has suggested that for bloodstream infections (BSIs) due to
extended-spectrum β-lactamase–producing Enterobacteriaceae (ESBL) Escherichia coli …

Objective: To review the laboratory diagnosis of extended-spectrum β-lactamase (ESBL)
and AmpC β-lactamase–producing bacteria and evaluate potential treatment options. Data …